-
The 8th Tongji Breast Cancer Forum | Professor Huihua Xiong: Integrating Top Academic Expertise to Advance Regional Breast Cancer Care
With the arrival of spring, the 8th Tongji Breast Cancer Forum was successfully convened, focusing on key topics including clinical needs, cutting-edge advances, grassroots implementation, and the development of young physicians. The meeting not only built a bridge for in-depth dialogue between leading experts and frontline clinicians, but also offered fresh perspectives on integrating clinical…
-
CSCO BC Preview | Professor Zefei Jiang: A Decade of Progress and a New Beginning—Join Us at the 2026 National Breast Cancer Conference
From April 10 to 12, 2026, the National Breast Cancer Conference will be held in Beijing. Marking the 10th anniversary of the Breast Cancer Committee of the Chinese Society of Clinical Oncology (CSCO BC), this annual flagship meeting will once again bring together leading experts from China and around the world to share cutting-edge research,…
-
Beijing · April 24–25 | 2026 Beijing International Hematopoietic Stem Cell Transplantation Symposium (AOT 2026) to Convene
In order to comprehensively advance public health and strengthen strategies for the prevention and treatment of major diseases, medical innovation and international collaboration have become pivotal forces in overcoming critical health challenges. Against this backdrop, the 2026 Beijing International Hematopoietic Stem Cell Transplantation Symposium (Art of Transplant: Beijing Hematopoietic Stem Cell Transplantation Symposium, AOT 2026),…
-
Voice of China at EBMT 2026 | Professor Erlie Jiang / Dr. Xiaoyu Zhang: Exploring the Role of Third-Generation TKIs in Transplantation for Blast-Phase CML
From March 22 to 25, 2026, the 52nd Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT) was held in Madrid, Spain. As one of the most influential academic events in the field, the meeting brought together thousands of experts worldwide to discuss the latest advances in transplantation and cellular therapy.
-
Professor Haixia Fu: Applications and Advances of TPO Receptor Agonists and ATRA in the Treatment of ITP
From March 27 to 28, 2026, the 9th Beijing Conference on Thrombosis and Hemostasis, hosted by the Hematologic Immunology Branch of the Chinese Society of Immunology, together with the 7th Beijing Summit Forum on Hematologic Malignancies and Immunology, was successfully held in Beijing. The meeting brought together leading international and domestic experts, clinicians, and industry…
-
Breaking Mechanistic Barriers, Advancing Therapeutics — Professor Zeping Zhou on New Developments and Long-Term Management Strategies in ITP
Immune thrombocytopenia (ITP) is a complex autoimmune disorder involving multiple immune pathways and abnormalities in platelet production. In recent years, continuous advances in drug development and evolving treatment paradigms have been reshaping the clinical landscape of ITP.
-
Professor Heyu Ni: Interactions Between Platelets and the Immune System and Their Significance in Immune-Mediated Thrombocytopenia
From March 27 to 28, 2026, the 9th Beijing Conference on Thrombosis and Hemostasis and the 7th Beijing Summit Forum on Hematologic Malignancies and Immunology was successfully held in Beijing. The event brought together leading scholars, clinicians, and industry experts from around the world to exchange insights on cutting-edge developments in thrombosis and hemostasis, hematologic…
-
Annual Meeting of the Hematology Branch of the China International Exchange and Promotive Association for Medical and Health Care
Thrombotic diseases are associated with high incidence, mortality, and disability rates, posing a serious threat to public health. Venous thromboembolism (VTE), in particular, often presents insidiously, and dislodged thrombi can lead to pulmonary embolism—earning it the reputation of a “silent killer.”
Connecting Medical Expertise through Media